Julz

Calcivis, a privately held company based in Edinburgh, Scotland, was founded in 2012 to address a significant need in the field of dentistry. The company specializes in a dental imaging platform that offers visual evidence of tooth demineralization, enabling dentists to identify active decay at an early stage. This innovative technology, co-invented with the University of Dundee and LUX Innovate, allows for the differentiation between active and non-active lesions on tooth surfaces, promoting preventive dentistry. By facilitating early intervention, Calcivis aims to help prevent the progression of cavities that would otherwise require invasive treatments. The company operates using a virtual development model, collaborating with various contract research and manufacturing organizations primarily located in Scotland.

PhotoniCare, Inc. is a medical device company based in Champaign, Illinois, founded in 2013. The company specializes in developing innovative diagnostic tools for middle ear infections, notably the TOMi Scope. This handheld device employs advanced light-based technology, specifically near-infrared light waves, to create 3D images of the middle ear by seeing through the eardrum. This capability allows physicians to visualize the middle ear directly and safely, enabling them to assess its condition quickly and accurately. By determining the contents of the middle ear, clinicians can make informed decisions regarding the need for antibiotics or surgical interventions. PhotoniCare's technology not only addresses otology but also presents potential for growth in other medical fields.

SurgaColl Technologies Ltd., established in 2010 and headquartered in Cork, Ireland, is a medical devices company specializing in the development, production, and marketing of innovative tissue regeneration products. These products, based on technology originating from the Royal College of Surgeons in Ireland, support the body's natural healing processes. SurgaColl's portfolio includes HydroxyColl, a bone graft substitute, and ChondroColl, a biomimetic scaffold for osteochondral defect repair. The company's mission is to lead the field of regenerative medical devices, promoting faster tissue regeneration and enabling patients to return to a healthy, active lifestyle.

Calcivis, a privately held company based in Edinburgh, Scotland, was founded in 2012 to address a significant need in the field of dentistry. The company specializes in a dental imaging platform that offers visual evidence of tooth demineralization, enabling dentists to identify active decay at an early stage. This innovative technology, co-invented with the University of Dundee and LUX Innovate, allows for the differentiation between active and non-active lesions on tooth surfaces, promoting preventive dentistry. By facilitating early intervention, Calcivis aims to help prevent the progression of cavities that would otherwise require invasive treatments. The company operates using a virtual development model, collaborating with various contract research and manufacturing organizations primarily located in Scotland.

Pathfinder Medical is focused on creating a novel electronic guidance system that facilitates minimally invasive connections between blood vessels. This innovative catheter-based technology is designed specifically for treating kidney failure, allowing for vascular access creation that can be performed outside of traditional operating rooms. The system aims to improve the reliability of hemodialysis access for patients, addressing a significant market opportunity valued at £1.6 billion annually. By reducing the likelihood of failure, Pathfinder Medical’s solution enhances treatment options for patients requiring dialysis, showcasing its potential impact in the healthcare sector.